EXPORT CITATION

Chapter-44 Bleeding Child in the PICU

BOOK TITLE: IAP Textbook of Pediatric ICU Protocols

Author
1. Ramachandran Bala
2. Ravikumar KG
3. Kumar K Senthil
ISBN
9789350903704
DOI
10.5005/jp/books/11878_44
Edition
2/e
Publishing Year
2013
Pages
6
Author Affiliations
1. KKCT Hospital, Chennai, Tamil Nadu, India, Kanchi Kamakoti, Childs Trust Hospital, 12A Nageswara Road, Nungambakkam, Chennai, Tamil Nadu, India, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, Tamil Nadu, India, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu, Kanchi Kamakoti Child Trust Hospital, Chennai, Tamil Nadu, India, Kanchi Kamakoti CHILDS, Trust Hospital, Chennai, Tamil Nadu, India
2. Kanchi Kamakoti CHILDS Trust Hospital, Chennai, Tamil Nadu, India, KKCT Hospital, Chennai, Tamil Nadu, India
3. KKCT Hospital, Chennai, Tamil Nadu, India
Chapter keywords
Bleeding child, Platelet-related disorders, Coagulation disorders, Bleeding disorders, Vitamin K deficiency, Activated partial thromboplastin time, Pediatric platelet transfusions, Clotting factor concentrates, Recombinant factor VIIa therapy

Abstract

A bleeding child in the pediatric intensive care unit (PICU) shows platelet-related and coagulation disorders. While taking the medical history of such child, factors like the sites of bleeding, the severity and duration of bleeding, and the age at onset should be considered. Family history is obtained by asking questions about previous surgical procedures, dental extractions, and transfusions of all family members, as well as the menstrual and obstetric histories of female relatives. Patients with significant bleeding disorders are to be examined for bruises in any area that appear excessively large for the degree of trauma or for underlying palpable hematomas. A complete blood count, peripheral blood smear and coagulation studies are carried out to rule out any bleeding disorder. Quantitative and qualitative aspects of platelet disorders in PICU are discussed. Management of bleeding child is by administration of vitamin K, platelets and clotting factor concentrates. Other treatment includes recombinant factor VIIIa therapy.

Related Books

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved